Document is current
Any future updates will be listed below
-
Authors
Geevarghese, Ruben
Kiely, Leah
Petre, Elena N.
Solomon, Stephen B.
Cornelis, Francois H. https://orcid.org/0000-0002-1058-0884
-
Funding
Funding for this research was provided by:
NIH/NCI Cancer Center Support Grant (P30 CA008748)
- License Information
-
More Information
Article History
Received: 28 September 2025
Accepted: 31 May 2026
First Online: 8 June 2026
Declarations
:
: Institutional review board approval was obtained for the case series (Memorial Sloan Kettering Cancer Center Institutional Review Board—Protocol Number: 16–402). The requirement for informed consent was waived by the Institutional Review Board.
: Not applicable.
: F.H.C. is a consultant for GE HealthCare. S.B.S. is a consultant for GE HealthCare, Merck, and Obsidian; receives grants or contracts from GE HealthCare and Johnson & Johnson; and reports participation in data safety monitoring board of Candel Therapeutics and Impact Biotech and stock or stock options in Johnson & Johnson.
